Incyte to acquire Vega Therapeutics for $1.25 billion upfront
Tweet Send to a Friend
Incyte Corp. (NASDAQ: INCY) announced it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


